Psoriasis: facial psoriasis

LAST UPDATED: Nov 18, 2021

Introduction

This chapter discusses the management of facial psoriasis and is set out as follows:


Clinical findings

  • The face is a relatively uncommon site 
  • Patients occasionally present with well-demarcated plaques. A more frequent finding is similar to that seen in seborrhoeic dermatitis, indeed the two can be very difficult to tell apart and as such this presentation is sometime referred to as sebo-psoriasis

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

The face, along with the hands and genitalia represent important cosmetic areas and the presence of psoriasis at these sites produces disproportionate distress. Improving psoriasis at these sites is of great importance.

  • Emollients are required by all patients
  • Active treatments include:
    • The most effective treatment is Tacrolimus 0.1% ointment OD-BD
    • The vitamin D analogues - Curatoderm ® lotion / ointment and Silkis ® ointment
    • Although weaker topical steroids such as 1% Hydrocortisone or Eumovate ® can be used, there is a risk of atrophy and so they should only be used on an intermittent basis. Eumovate ® can be safely used as an effective treatment for the hairline and ears

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco